bepabeplay2021欧洲杯官网ly提款到银行卡新闻文件药品新闻发布 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com 最新的药品新闻发布来自NewsFile Corp,合规解决方案提供商的公共公司。bepaly提款到银行卡beplay2021欧洲杯官网 bepabeplay2021欧洲杯官网ly提款到银行卡新闻文件药品新闻发布 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/images/newsfileLogo.pnghttps://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com 念头美国 Office@bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com(新闻福明公司) Office@bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com(新闻福明公司) 版权所有(c)2021,Newsfilebepabeplay2021欧洲杯官网ly提款到银行卡 Corp.保留所有权利。 星期二,11月11日2021年17:05:02 EDT 2021年5月31日星期一的迷幻投资系列施工健康 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83670/Psyched-Wellness-to-Present-at-the-Psychedelic-Investment-Series-on-Monday-May-31-2021 http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83670/Psyched-Wellness-to-Present-at-the-Psychedelic-Investment-Series-on-Monday-May-31-2021 Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company will be participating in the upcoming Psychedelic Capital virtual event. Psyched will be presenting at the next... 星期二,11月11日2021年17:01:00 -0400 PAOG确认CBD营养品第四季度收入计划 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83658/PAOG-Confirms-CBD-Nutraceutical-Q4-Revenue-Plans http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83658/paog-confirms-cbd-nutraceutical-q4-revenue-plans. Sandusky,俄亥俄州 - (Newsfile corp. - 5月11日,2021) - Pao Group,Inc。(OTC Pink:Paog)今天确认计划于今年第四季度介绍三个CBD营养品产品,2021.on星期五,PAOG发布了公司计划推出CBD营养品生产线的计划。睡眠的CBD Nutraceuticals预计今年将在2021年产生收入,而该公司继续其长期CBD药业发展.Paog正在努力...... 2021年5月11日星期二14:58:00 -0400 iCo Therapeutics子公司在国家药学会议上介绍口服两性霉素B / SARS-Cov-2研究成果 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83551/ico-thease/83551/ico-thereputics-subsidiary-to-present-oral-amphotericin-b-sarscov2-research-results-at-national-pharmaceuty-ciences-meeting. http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83551/ico-therapeutics-subsidiary-to-present-or-amphotericin-b-sarscov2-research-results-at-national-pharmaceuty-ciences-meeting. 温哥华,不列颠哥伦比亚省 - (新闻福明公司 - 5月11日,2021) - Amphyericin B Technologies,Inc(“AMP B Tech”或“公司”)是ICO Therapeutics,Inc。(TSXV:ICO)(“ico”)的全资子公司(“ico”),今天宣布,这两项介绍了与公司口腔两性霉素B配方的有效性研究有关(“ICO 019”“)在SARS-COV-2病毒上被接受到2021个CSP / PSJ / CC-CRS联合研讨会 - 在大流行世界中的药物科学。研讨会将...... 2021年5月11日星期二08:00:00 -0400 Annovis Bio参加Benzinga Global Small Cop会议,并于2021年5月13日向投资者展示 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83598/annovis-bio-to-participate-at-the-benzinga-global-small-cap-conference-and-present-to-investors-ton-may-13-2021. http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83598/Annovis-Bio-to-Participate-at-the-Benzinga-Global-Small-Cap-Conference-and-Present-to-Investors-on-May-13-2021 Berwyn, Pennsylvania--(Newsfile Corp. - May 11, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced that management will participate at the Benzinga Global Small Cap Conference taking place online May 13-14, 2021.Annovis Bio CEO Maria Maccecchini, Ph.D. will deliver a corporate presentation at 3:10 p.m. ET on May 13, 2021. Investors can request a one-on-one meeting with Dr.... 星期二,11月11日06:45:00 -0400 止血创汇宣布私人配售结束 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83571/Hemostemix-Announces-Closing-of-Unit-Private-Placement http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83571/hemostemix-announces-closent-of-unit-private -placement. Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed its previously announced non-brokered private placement of units ("Units") announced on April 9, 2021, for gross proceeds of $440,031.90 (the "Offering"). The Offering consisted of the issuance of an aggregate of 1,257,234 Units at a price of $0.35 per Unit. Each Unit consists of one common share in the capital of... 星期一,5月10日2021 22:16:00 -0400 Innocan制药聘请莱瑟姆合作伙伴领导投资者关系和股东沟通项目 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83474/innocan-pharma-engages --lytham-partners-to-lead-investor-relations-and-shareholder-communication-program. http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83474/innocan-pharma-engages --lytham-partners-to-lead-investor-relations-ands-shareholder-communication-program. 赫兹利亚,以色列和卡尔加里,艾伯塔省 - (新闻福明公司 - 5月10日,2021年) - Innocan Pharma Corporation(CSE:Inno)(FSE:IP4)(OTCQB:InnPF)(“公司”或“Innocan”)今天宣布它保留了Lytham Partners,LLC(“Lytham Partners”),以引领投资者关系和股东通信计划。超过20年,Lytham Partners一直是该行业领先的投资者关系公司之一,创造了一个最大,最多样化的机构投资者网络之一,同时创造...... 星期一,10月10日2021年16:00:00 -0400 Annovis Bio在纽约证券交易所响铃响铃 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83476/annovis-bio-to ring-closing-bell-at-the-new-york-stock-exchange. http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83476/annovis-bio-to-tring-closing-bell-at-the-new-york-stock-exchange. Berwyn, Pennsylvania--(Newsfile Corp. - May 10, 2021) -  Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, is pleased to announce that its CEO Maria Maccecchini, Ph.D. will ring The Closing Bell at the New York Stock Exchange (NYSE) today, May 10, to celebrate the recent reporting of positive interim data from its ongoing Phase 2a trial in AD and PD."We are... 星期一,5月10日2021年14:00:00 -0400 Neovasc宣布在Cosima审判中首次患者入学 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83420/Neovasc-Announces-First-Patient-Enrollment-in-COSIMA-Trial http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83420/neovasc-announces-first-patient-enrollment-in-cosima-trial. 温哥华,不列颠哥伦比亚省和明尼阿波利斯,明尼苏达州 - (新闻福明公司 - 5月10日,2021) - Neovasc Inc.(纳斯达克:NVCN)(TSX:NVCN)(“Neovasc”或“公司”)今天宣布,第一个患者已注册冠状窦减速剂,用于治疗难治性微血管术(“COSIMA”)试验。入学人员发生在德国华美州大学医院。患者是一名82岁的女性,仍然患有严重的加拿大心血管社会(“CCS”)阶级IV Angina,尽管如此...... 星期一,5月10日2021 09:05:00 -0400 TRYP治疗方法与Clinlogix合作临床试验支持 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83418/Tryp-Therapeutics-Partners-with-Clinlogix-for-Clinical-Trial-Support http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83418/Tryp-Therapeutics-Partners-with-Clinlogix-for-Clinical-Trial-Support San Diego, California--(Newsfile Corp. - May 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today a master service agreement with Clinlogix, a Contract Research Organization (CRO), to support Tryp's clinical development of its Psilocybin-for-Neuropsychiatric Disorders (PFNTM) program.Clinlogix has global experience with providing CRO services for the development of novel pharmaceutical products. The company will collaborate with... 2021年5月10日星期一04:00:00 -0400 Nerggen Pharma赠送股票选项 https://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83385/NervGen-Pharma-Grants-Stock-Options http://www.bepabeplay2021欧洲杯官网ly提款到银行卡newsfilecorp.com/release/83385/nervgen-Pharma-grants-stock-Options. 不列颠哥伦比亚省温哥华 - (新闻福明公司 - 5月7日,2021年) - Nerggen Pharma Corp.(Tsxv:ngen)(otcqx:nggenf)(“神经根源”或“公司”),一家临床阶段生物技术公司,致力于为神经损伤和神经退行性疾病发展创新治疗,今天宣布,该公司已向该公司的一名官员授予800,000次激励股权,并在该公司的官员中行使每股1.51美元的价格为10年,并将其背心同样每六个月一次...... 2021年5月7日星期五19:26:00 -0400